Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 05, 2016 $2.64 $2.86 $2.51 $2.84 334 178
Apr 04, 2016 $2.56 $3.04 $2.54 $2.76 1 054 570
Apr 01, 2016 $2.12 $2.58 $2.12 $2.53 507 856
Mar 31, 2016 $2.09 $2.20 $2.08 $2.14 180 444
Mar 30, 2016 $2.11 $2.13 $2.08 $2.12 44 405
Mar 29, 2016 $2.10 $2.13 $2.05 $2.11 168 600
Mar 28, 2016 $2.10 $2.15 $2.05 $2.10 115 400
Mar 24, 2016 $2.05 $2.10 $2.04 $2.09 42 900
Mar 23, 2016 $2.09 $2.14 $2.04 $2.05 129 900
Mar 22, 2016 $2.02 $2.13 $2.02 $2.10 161 200
Mar 21, 2016 $2.01 $2.05 $1.97 $2.03 132 500
Mar 18, 2016 $1.92 $2.00 $1.90 $1.99 182 300
Mar 17, 2016 $1.92 $1.96 $1.83 $1.91 119 600
Mar 16, 2016 $1.91 $1.97 $1.89 $1.93 122 300
Mar 15, 2016 $2.00 $2.04 $1.90 $1.90 147 700
Mar 14, 2016 $2.04 $2.09 $2.00 $2.03 134 400
Mar 11, 2016 $2.07 $2.14 $1.98 $2.02 91 500
Mar 10, 2016 $1.95 $2.10 $1.95 $2.00 250 000
Mar 09, 2016 $2.15 $2.19 $1.95 $2.07 119 800
Mar 08, 2016 $2.24 $2.33 $2.11 $2.11 203 600
Mar 07, 2016 $2.08 $2.25 $2.08 $2.24 167 500
Mar 04, 2016 $2.01 $2.20 $2.01 $2.05 156 000
Mar 03, 2016 $1.94 $2.13 $1.94 $2.03 170 200
Mar 02, 2016 $1.77 $1.93 $1.76 $1.92 201 900
Mar 01, 2016 $1.80 $1.88 $1.77 $1.78 110 400
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT